Insights on the Cervical Dysplasia Diagnostics Global Market to 2027 - Featuring Hologic, QIAGEN & Quest Diagnostics Among Others - ResearchAndMarkets.com

DUBLIN--()--The "Cervical Dysplasia Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 7th edition of this report. The 184-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Cervical Dysplasia Diagnostics Market to Reach $661.7 Million by 2027

Amid the COVID-19 crisis, the global market for Cervical Dysplasia Diagnostics estimated at US$446.5 Million in the year 2020, is projected to reach a revised size of US$661.7 Million by 2027, growing at a CAGR of 5.8% over the period 2020-2027. Diagnostic Tests, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$584.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Diagnostic Devices segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U. S. Market is Estimated at $131.7 Million, While China is Forecast to Grow at 5.4% CAGR

The Cervical Dysplasia Diagnostics market in the U. S. is estimated at US$131.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$116.4 Million by the year 2027 trailing a CAGR of 5.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Competitors identified in this market include, among others:

  • Abbott Molecular, Inc.
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Cervical Dysplasia Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/wxcu9y

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900